Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Federal Trade Commission

Generated: October 24, 2017

DrugPatentWatch Database Preview

AGRYLIN Drug Profile

« Back to Dashboard

Which patents cover Agrylin, and when can generic versions of Agrylin launch?

Agrylin is a drug marketed by Shire Llc and is included in one NDA.

The generic ingredient in AGRYLIN is anagrelide hydrochloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the anagrelide hydrochloride profile page.

Summary for Tradename: AGRYLIN

US Patents:0
Suppliers / Packagers: see list1
Bulk Api Vendors: see list52
Clinical Trials: see list3
Patent Applications: see list344
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AGRYLIN at DailyMed

Pharmacology for Tradename: AGRYLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Llc
anagrelide hydrochloride
CAPSULE;ORAL020333-001Mar 14, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Shire Llc
anagrelide hydrochloride
CAPSULE;ORAL020333-002Mar 14, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Farmers Insurance
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus